DIG
ICCC icon

Dauntless Investment Group’s ImmuCell ICCC Stock Holding History

Dauntless Investment Group’s Portfolio ICCC Stock Details ICCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-39,633
Closed -$244K – 82
2025
Q4 		$244K Sell
39,633
-47,488
-55% -$280K 0.19% 47
2025
Q3 		$545K Sell
87,121
-7,573
-8% -$47.9K 0.34% 41
2025
Q2 		$659K Sell
94,694
-36,501
-28% -$213K 1.15% 17
2025
Q1 		$628K Hold
131,195
– – 0.74% 25
2024
Q4 		$676K Buy
+131,195
New +$523K 0.71% 22

Other funds holding ICCC

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CAM
Cresset Asset Management Chicago, Illinois $27.6B AUM 31.92% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
S
Steadtrust Allen, Texas $198M AUM 99.37% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
MFIM
Mesirow Financial Investment Management Chicago, Illinois $6.37B AUM 23.22% 1-Year Est. Return

Dauntless Investment Group's ICCC Position: Q1 2026 in Review

Dauntless Investment Group sold out of ImmuCell (ICCC) in Q1 2026, closing a stake of 39,633 shares — an estimated $244K sold.

Dauntless Investment Group first reported a position in ICCC in Q4 2024 and held it in 5 quarters. The position peaked at $676K in Q4 2024. 27 funds tracked by Wall St. Rank hold ICCC as of Q1 2026.

  • Dauntless Investment Group reported no remaining ImmuCell position as of Q1 2026 after selling out during the quarter.
  • Dauntless Investment Group sold 39,633 ImmuCell shares in Q1 2026, an estimated $244K.
  • Dauntless Investment Group first reported a position in ImmuCell in Q4 2024 and held it in 5 quarters.
  • Dauntless Investment Group's ImmuCell position peaked at $676K in Q4 2024.
  • 27 funds tracked by Wall St. Rank held ImmuCell as of Q1 2026.

Based on Dauntless Investment Group's 13F filing for Q1 2026, filed 14 May 2026.